Search Results - "Hrnčiarová, Tereza"

Lipidomic profiling of human serum enables detection of pancreatic cancer by Wolrab, Denise, Jirásko, Robert, Cífková, Eva, Höring, Marcus, Mei, Ding, Chocholoušková, Michaela, Peterka, Ondřej, Idkowiak, Jakub, Hrnčiarová, Tereza, Kuchař, Ladislav, Ahrends, Robert, Brumarová, Radana, Friedecký, David, Vivo-Truyols, Gabriel, Škrha, Pavel, Škrha, Jan, Kučera, Radek, Melichar, Bohuslav, Liebisch, Gerhard, Burkhardt, Ralph, Wenk, Markus R., Cazenave-Gassiot, Amaury, Karásek, Petr, Novotný, Ivo, Greplová, Kristína, Hrstka, Roman, Holčapek, Michal

“…Pancreatic cancer has the worst prognosis among all cancers. Cancer screening of body fluids may improve the survival time prognosis of patients, who are often…”
Get full text

Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis by Srpova, Barbora, Uher, Tomas, Hrnciarova, Tereza, Barro, Christian, Andelova, Michaela, Michalak, Zuzanna, Vaneckova, Manuela, Krasensky, Jan, Noskova, Libuse, Havrdova, Eva Kubala, Kuhle, Jens, Horakova, Dana

“…Background: Serum neurofilament light chain (sNfL) is a marker of neuroaxonal injury. There is a lack of studies investigating the dynamics of relationships…”
Get full text

Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis by Mlcoch, Tomas, Hrnciarova, Tereza, Tuzil, Jan, Zadak, Jakub, Marian, Marisca, Dolezal, Tomas

“…In situations of markedly different population characteristics and weak population overlap, inverse propensity score (PS) weights suffer from extreme values…”
Get full text

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines by Hensler, Michal, Rakova, Jana, Kasikova, Lenka, Lanickova, Tereza, Pasulka, Josef, Holicek, Peter, Hraska, Marek, Hrnciarova, Tereza, Kadlecova, Pavla, Schoenenberger, Andreu, Sochorova, Klara, Rozkova, Daniela, Sojka, Ludek, Drozenova, Jana, Laco, Jan, Horvath, Rudolf, Podrazil, Michal, Hongyan, Guo, Brtnicky, Tomas, Halaska, Michal J., Rob, Lukas, Ryska, Ales, Coosemans, An, Vergote, Ignace, Garg, Abhishek D., Cibula, David, Bartunkova, Jirina, Spisek, Radek, Fucikova, Jitka

“…Dendritic cells (DCs) have received considerable attention as potential targets for the development of novel cancer immunotherapies. However, the clinical…”
Get full text

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial by Rob, Lukas, Cibula, David, Knapp, Pawel, Mallmann, Peter, Klat, Jaroslav, Minar, Lubos, Bartos, Pavel, Chovanec, Josef, Valha, Petr, Pluta, Marek, Novotny, Zdenek, Spacek, Jiri, Melichar, Bohuslav, Kieszko, Dariusz, Fucikova, Jitka, Hrnciarova, Tereza, Korolkiewicz, Roman Pawel, Hraska, Marek, Bartunkova, Jirina, Spisek, Radek

“…BackgroundMost patients with epithelial ovarian cancer (EOC) relapse despite primary debulking surgery and chemotherapy (CT). Autologous dendritic cell…”
Get full text

Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis by Andelova, Michaela, Vodehnalova, Karolina, Krasensky, Jan, Hardubejova, Eliska, Hrnciarova, Tereza, Srpova, Barbora, Uher, Tomas, Menkyova, Ingrid, Stastna, Dominika, Friedova, Lucie, Motyl, Jiri, Lizrova Preiningerova, Jana, Kubala Havrdova, Eva, Maréchal, Bénédicte, Fartaria, Mário João, Kober, Tobias, Horakova, Dana, Vaneckova, Manuela

“…Background Early infratentorial and focal spinal cord lesions on magnetic resonance imaging (MRI) are associated with a higher risk of long-term disability in…”
Get full text

An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors by Fucikova, Jitka, Hensler, Michal, Kasikova, Lenka, Lanickova, Tereza, Pasulka, Josef, Rakova, Jana, Drozenova, Jana, Fredriksen, Tessa, Hraska, Marek, Hrnciarova, Tereza, Sochorova, Klara, Rozkova, Daniela, Sojka, Ludek, Dundr, Pavel, Laco, Jan, Brtnicky, Tomas, Praznovec, Ivan, Halaska, Michael J., Rob, Lukas, Ryska, Ales, Coosemans, An, Vergote, Ignace, Cibula, David, Bartunkova, Jirina, Galon, Jérôme, Galluzzi, Lorenzo, Spisek, Radek

“…PURPOSEThe successful implementation of immune checkpoint inhibitors (ICI) in the clinical management of various solid tumors has raised considerable…”
Get full text

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial by Cibula, David, Rob, Lukas, Mallmann, Peter, Knapp, Pawel, Klat, Jaroslav, Chovanec, Josef, Minar, Lubos, Melichar, Bohuslav, Hein, Alexander, Kieszko, Dariusz, Pluta, Marek, Spacek, Jiri, Bartos, Pavel, Wimberger, Pauline, Madry, Radoslaw, Markowska, Janina, Streb, Joanna, Valha, Petr, Hassan, Hariz Iskandar Bin, Pecen, Ladislav, Galluzzi, Lorenzo, Fucikova, Jitka, Hrnciarova, Tereza, Hraska, Marek, Bartunkova, Jirina, Spisek, Radek

“…DCVAC/OvCa is an active cellular immunotherapy designed to stimulate an immune response against ovarian cancer. We explored the safety and efficacy of…”
Get full text

Dendritic cell vaccine (DCVAC) combined with chemotherapy (CMT) in patients with newly diagnosed epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Biomarker exploratory analysis of a phase 2, open-label, randomized, multicenter trial by Rob, Lukas, Cibula, David, Knapp, Pawel, Mallmann, Peter, Klat, Jaroslav, Minar, Lubos, Bartos, Pavel, Chovanec, Josef, Valha, Petr, Pluta, Marek, Novotny, Zdenek, Spacek, Jiri, Melichar, Bohuslav, Kieszko, Dariusz, Fucikova, Jitka, Hrnciarova, Tereza, Korolkiewicz, Roman Pawel, Hraska, Marek, Bartunkova, Jirina, Spisek, Radek

“…Abstract only 5521 Background: Most patients with EOC relapse despite PDS and CMT. Autologous DCVAC can present tumor antigens to elicit a durable immune…”
Get full text

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection by Stastna, Dominika, Menkyova, Ingrid, Drahota, Jiri, Hrnciarova, Tereza, Kubala Havrdova, Eva, Vachova, Marta, Andelova, Michaela, Kleinova, Pavlina, Kovarova, Ivana, Krasulova, Eva, Preiningerova, Jana Lizrova, Novakova, Iveta, Novotna, Klara, Novotna, Martina, Nytrova, Petra, Pavlickova, Jana, Srpova, Barbora, Storey, Katerina, Ticha, Veronika, Tyblova, Michaela, Uher, Tomas, Vodehnalova, Karolina, Horakova, Dana

“…•There is an increase in the MS relapse incidence after COVID-19 infection.•There is a mild increase in the MS relapse incidence after COVID-19…”
Get full text

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014] by Stastna, Dominika, Menkyova, Ingrid, Drahota, Jiri, Hrnciarova, Tereza, Kubala Havrdova, Eva, Vachova, Marta, Andelova, Michaela, Kleinova, Pavlina, Kovarova, Ivana, Krasulova, Eva, Lizrova Preiningerova, Jana, Novakova, Iveta, Novotna, Klara, Novotna, Martina, Nytrova, Petra, Pavlickova, Jana, Srpova, Barbora, Storey, Katerina, Ticha, Veronika, Tyblova, Michaela, Uher, Tomas, Vodehnalova, Karolina, Horakova, Dana

Get full text

Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis by Mlcoch, Tomas, Tuzil, Jan, Sedova, Liliana, Stolfa, Jiri, Urbanova, Monika, Suchy, David, Smrzova, Andrea, Jircikova, Jitka, Hrnciarova, Tereza, Pavelka, Karel, Dolezal, Tomas

“…Background Clinical trials and observational studies lacking measures of health-related quality of life (QoL) are often inapplicable when conducting…”
Get full text

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries by Hrnciarova, Tereza, Drahota, Jiri, Spelman, Tim, Hillert, Jan, Lycke, Jan, Kubala Havrdova, Eva, Recmanova, Eva, Adamkova, Jana, Mares, Jan, Libertinova, Jana, Pavelek, Zbysek, Hradilek, Pavel, Ampapa, Radek, Stetkarova, Ivana, Peterka, Marek, Martinkova, Alena, Stourac, Pavel, Grunermelova, Marketa, Vachova, Marta, Dufek, Michal, Horakova, Dana

“…•Direct initiation of moderate-high efficacy therapy seems beneficial.•Moderate-high efficacy therapy does not lead to treatment switch due to adverse…”
Get full text